Research Summary
Analyzed using Evidence Intelligence™

eHealth app improves glycemic control in diabetes patients

Last updated August 24, 2026

Key finding

The intervention group showed significantly lower mean HbA1c levels (mean 6.76%, SD 0.64%) compared to the control group (mean 7.09%, SD 0.82%, P =.007).

This study evaluated an eHealth chronic disease management module's effect on glycemic control in diabetes patients, finding significant improvements in HbA1c levels.

Quick read

Study at a glance

The essential study design details in one scan.

EvidenceScore™

Moderate

Study type

RCTs

Follow-up

Long-Term (1–5 y)

Risk of bias

Some Concerns

Save research, organize studies, and quickly find important evidence again.

Plain-language summary

What this paper says

A plain-language read of the study’s main message and where it applies.

Study focus

This study evaluated an eHealth chronic disease management module's effect on glycemic control in diabetes patients, finding significant improvements in HbA1c levels.

Clinical relevance

Improving glycemic control is crucial for diabetes management, as it can reduce the risk of complications. This study suggests that eHealth interventions can be effective tools for enhancing patient outcomes, making them valuable in clinical practice for managing diabetes.

Keep in mind

The study's sample size may limit generalizability. No significant changes were observed in blood pressure or kidney function. Long-term effects of the intervention were not assessed.

Published in

Journal Reference

Publication details and source links for this paper.

Amaryllis M, Abdul NA, Daniel T, et al. The Impact of an eHealth Chronic Disease Management Module on Glycemic Control in Patients with Diabetes: A Randomized Controlled Trial. JMIR Formative Research. 2025;9:e67761. doi:10.2196/67761

Main Effects

The intervention group showed a decrease in mean HbA1c levels by 0.33% (P = 0.007).

73.4% of the intervention group achieved optimal HbA1c levels compared to 49.3% in the control group (P = 0.004).

App usage scores decreased by 0.49 points from month 4 to month 8 (P < 0.001).

Evidence network

How this study fits

Understand where this research contributes within the broader evidence network.

Evidence Context

This study contributes evidence to eHealth chronic disease management module and Achievement of HbA1c ≤ 6.5%, App usage score, Diastolic blood pressure, and 4 more.

Primary intervention

eHealth chronic disease management module

Primary outcomes

  • Achievement of HbA1c ≤ 6.5%
  • App usage score
  • Diastolic blood pressure

Evidence relationships

Intervention and outcome relationships this study adds to the evidence network.

7
Evidence pairs
7
Relationships
2
Evidence topics
contributes_evidence

Editorial context

Why this study matters

See why this paper is useful beyond its individual results.

Evidence network role

This section describes how the study fits into the current evidence network. It does not determine whether an intervention works on its own.

Moderate contributionModerate confidenceNetwork score: 68

2

Related topics

7

Evidence pairs

743

Related studies

High relevance in at least one topic

Why it is useful

  • Contributes to 7 evidence relationships
  • Includes primary outcome data
  • Linked to 2 direct semantic evidence topics

Topic contributions

Evidence topic

Contributes evidence

Evidence topic

Contributes evidence

Add related evidence to your Evidence Tracker

Save studies and evidence pages, organize your personal Evidence Tracker, and keep the research you care about in one place.

Primary evidence

Evidence topic

Blood Pressure

matched_outcome

Related evidence

Evidence topic

HbA1c Reduction

Save evidence

Core evidence

Study findings

The primary outcomes reported in this study.

Achievement of HbA1c ≤ 6.5%

eHealth chronic disease management module → Achievement of HbA1c ≤ 6.5%

eHealth chronic disease management module → Achievement of HbA1c ≤ 6.5%

Evidence Intelligence™
EvidenceScore™
Emerging
Score 59 · Based on 1 study
ImpactScore™
100
Very Positive
ConsistencyScore™
unclear
Not enough independent studies
Supporting studies: Based on 1 study
Add to Evidence Tracker

App usage score

eHealth chronic disease management module → App usage score

eHealth chronic disease management module → App usage score

Evidence Intelligence™
EvidenceScore™
Emerging
Score 59 · Based on 1 study
ImpactScore™
50
Neutral
ConsistencyScore™
unclear
Not enough independent studies
Supporting studies: Based on 1 study
Add to Evidence Tracker

Diastolic blood pressure

eHealth chronic disease management module → Diastolic blood pressure

eHealth chronic disease management module → Diastolic blood pressure

Evidence Intelligence™
EvidenceScore™
Emerging
Score 59 · Based on 1 study
ImpactScore™
50
Neutral
ConsistencyScore™
unclear
Not enough independent studies
Supporting studies: Based on 1 study
Add to Evidence Tracker

Estimated glomerular filtration rate

eHealth chronic disease management module → Estimated glomerular filtration rate

eHealth chronic disease management module → Estimated glomerular filtration rate

Evidence Intelligence™
EvidenceScore™
Emerging
Score 59 · Based on 1 study
ImpactScore™
50
Neutral
ConsistencyScore™
unclear
Not enough independent studies
Supporting studies: Based on 1 study
Add to Evidence Tracker

HbA1c

eHealth chronic disease management module → HbA1c

eHealth chronic disease management module → HbA1c

Evidence Intelligence™
EvidenceScore™
Emerging
Score 59 · Based on 1 study
ImpactScore™
100
Very Positive
ConsistencyScore™
unclear
Not enough independent studies
Supporting studies: Based on 1 study
Add to Evidence Tracker

Systolic blood pressure

eHealth chronic disease management module → Systolic blood pressure

eHealth chronic disease management module → Systolic blood pressure

Evidence Intelligence™
EvidenceScore™
Emerging
Score 59 · Based on 1 study
ImpactScore™
50
Neutral
ConsistencyScore™
unclear
Not enough independent studies
Supporting studies: Based on 1 study
Add to Evidence Tracker

Urinary albumin-to-creatinine ratio

eHealth chronic disease management module → Urinary albumin-to-creatinine ratio

eHealth chronic disease management module → Urinary albumin-to-creatinine ratio

Evidence Intelligence™
EvidenceScore™
Emerging
Score 59 · Based on 1 study
ImpactScore™
50
Neutral
ConsistencyScore™
unclear
Not enough independent studies
Supporting studies: Based on 1 study
Add to Evidence Tracker

Evidence Library

Build your evidence library

Save research, organize studies, and quickly find important evidence again.

evidence suggest

Evidence Suggest

  • Intervention group HbA1c levels decreased by 0.33%.
  • 24.1% more participants achieved optimal HbA1c levels with the intervention.
  • App usage decreased significantly over the study period.
who this applies

Who this applies to

  • Adults diagnosed with diabetes.
  • Patients seeking to improve glycemic control through digital health solutions.
keep in mind

Keep in Mind

  • Results may not apply to all diabetes types or age groups.
  • The decline in app usage may affect long-term outcomes.
  • Further studies are needed to assess long-term effectiveness.
between the lines

Between the Lines

  • The study's sample size may limit generalizability.
  • No significant changes were observed in blood pressure or kidney function.
  • Long-term effects of the intervention were not assessed.

Evidence Library

Build your evidence library

Save research, organize studies, and quickly find important evidence again.

Connected Evidence

Explore related studies, evidence collections, and research questions.

Relationships organized using the Dediabetes Evidence Intelligence™ framework.

This study contributes to evidence on eHealth chronic disease management module and Achievement of HbA1c ≤ 6.5%, eHealth chronic disease management module and App usage score.

Related evidence relationships

Explore in Evidence Explorer

This study contributes to the evidence on the following intervention-outcome relationships.

Included in these evidence collections

Curated evidence collections and hubs this study is part of.

Questions answered by this study

Generated from the study's connected evidence using Evidence Intelligence™.

Does eHealth chronic disease management module improve achievement of HbA1c ≤ 6.5%?

Emerging Evidence

eHealth chronic disease management module appears to improve achievement of HbA1c ≤ 6.5%.

ConsistencyScore™: Consistency cannot yet be determined from the available evidence.

Ranked evidence signals

  1. 1

    Achievement of HbA1c ≤ 6.5%

    EvidenceScore™ Emerging | EvidenceScore™ 59.0 | strong positive | ConsistencyScore™ Unclear | 1 study

Why this answer: This answer is based on a single supporting study.

Limitations

  • Only one supporting study is available.
1 supporting study

Does eHealth chronic disease management module lower HbA1c?

Emerging Evidence

eHealth chronic disease management module appears to lower HbA1c.

ConsistencyScore™: Consistency cannot yet be determined from the available evidence.

Ranked evidence signals

  1. 1

    HbA1c

    EvidenceScore™ Emerging | EvidenceScore™ 59.0 | strong positive | ConsistencyScore™ Unclear | 1 study

Why this answer: This answer is based on a single supporting study.

Limitations

  • Only one supporting study is available.
1 supporting study

Does eHealth chronic disease management module improve app usage score?

Emerging Evidence

Current evidence does not show a clear benefit of eHealth chronic disease management module for app usage score.

ConsistencyScore™: Consistency cannot yet be determined from the available evidence.

Ranked evidence signals

  1. 1

    App usage score

    EvidenceScore™ Emerging | EvidenceScore™ 59.0 | neutral | ConsistencyScore™ Unclear | 1 study

Why this answer: This answer is based on a single supporting study.

Limitations

  • Only one supporting study is available.
1 supporting study

Does eHealth chronic disease management module improve diastolic blood pressure?

Emerging Evidence

Current evidence does not show a clear benefit of eHealth chronic disease management module for diastolic blood pressure.

ConsistencyScore™: Consistency cannot yet be determined from the available evidence.

Ranked evidence signals

  1. 1

    Diastolic blood pressure

    EvidenceScore™ Emerging | EvidenceScore™ 59.0 | neutral | ConsistencyScore™ Unclear | 1 study

Why this answer: This answer is based on a single supporting study.

Limitations

  • Only one supporting study is available.
1 supporting study
Learn how Evidence Intelligence™ works

Next steps

Continue your research

Choose a next path through related evidence topics, Evidence Explorer views, and research summaries.

No ads. No tracking.

Focused on evidence, not advertising.

Secure & private

Your data is always protected.

Always up to date

New studies added every day.